MyFinsight
Home
Blog
About
Proceeds from issuance of
common stock under...
$1,377K
(19.64%↑ Y/Y)
Net cash provided by
financing activities
$1,176K
(-93.88%↓ Y/Y)
Canceled cashflow
$201K
Net increase
(decrease) in cash and cash...
-$2,852K
(-130.25%↓ Y/Y)
Canceled cashflow
$1,176K
Stock-based compensation
expense
$2,303K
(-60.66%↓ Y/Y)
Accrued liabilities
$1,506K
(1355.00%↑ Y/Y)
Amortization of right-of-use
asset
$464K
(-44.43%↓ Y/Y)
Non-cash interest
expense
$80K
(-79.49%↓ Y/Y)
Amortization of debt discount
and issuance costs
$70K
(-32.69%↓ Y/Y)
Inventory write-downs
$68K
(-26.88%↓ Y/Y)
Depreciation
$66K
(-34.00%↓ Y/Y)
Prepaid expenses and
other assets
-$63K
(90.61%↑ Y/Y)
Unrealized loss on
short-term investments
-$41K
(0.00%↑ Y/Y)
Payment of annual debt
fee
$150K
Taxes withheld and
paid related to net...
$51K
(-87.31%↓ Y/Y)
Net cash used in
operating activities
-$3,903K
(59.21%↑ Y/Y)
Canceled cashflow
$4,661K
Net cash used in
investing activities
-$125K
(39.02%↑ Y/Y)
Net loss
-$6,200K
(59.32%↑ Y/Y)
Inventory
$1,485K
(-51.44%↓ Y/Y)
Operating lease
liabilities
-$523K
(42.59%↑ Y/Y)
Accounts payable
-$212K
(-112.45%↓ Y/Y)
Accounts receivable
$141K
(-79.97%↓ Y/Y)
Deferred revenue
-$3K
(-102.13%↓ Y/Y)
Acquisition of property and
equipment
$125K
(-39.02%↓ Y/Y)
Back
Back
Cash Flow
NeuroPace Inc (NPCE)
NeuroPace Inc (NPCE)
source: myfinsight.com